FindMyKOL
Clinical trialNCT00031759CompletedPhase 2Interventional

Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia

SponsorAlliance for Clinical Trials in OncologyEnrollment57Cervical CancerPrecancerous Condition
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer. PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ccop - Mayo Clinic Scottsdale Oncology Program

    Scottsdale, Arizona, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Mbccop - Hawaii

    Honolulu, Hawaii, United States

  • Ccop - Carle Cancer Center

    Urbana, Illinois, United States

  • Ccop - Wichita

    Wichita, Kansas, United States

  • Ccop - Michigan Cancer Research Consortium

    Ann Arbor, Michigan, United States

  • Mayo Clinic Cancer Center

    Rochester, Minnesota, United States

  • Ccop - Sioux Community Cancer Consortium

    Sioux Falls, South Dakota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Imiquimod →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 1999
Primary completion
31 Jul 2004
Completion
28 Feb 2010
Last update posted
13 Jul 2016
Registered enrollment
57
Registry id
NCT00031759
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.